Latest Oncology Stories
Biomarker Analysis From Phase 3 PRIME ('203) Study and Phase 2 PEAK ('509) Study Link Additional RAS Gene Mutations to Vectibix Clinical Response THOUSAND OAKS, Calif., May 15, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced results from three analyses of Vectibix(®) (panitumumab) in combination with FOLFOX, an oxaliplatin-based chemotherapy regimen, as a first-line treatment for metastatic colorectal cancer (mCRC). These analyses include the description of new predictive...
CLEVELAND, May 15, 2013 /PRNewswire/ -- Researchers from University Hospitals Case Medical Center's (UHCMC) Seidman Cancer Center will present findings from two studies evaluating new technologies designed to address common barriers to patient enrollment in clinical trials. Results from a large-scale, randomized trial demonstrated that the use of tailored, web-based videos delivering educational information to patients before an oncologist visit can significantly improve knowledge and...
MANHATTAN BEACH, Calif., May 15, 2013 /PRNewswire/ -- A rigorous analysis of the Pancreatic Cancer Action Network research grants program has shown that the organization's grant recipients are leveraging their awards to secure impressive subsequent funding, publishing their findings, and enhancing knowledge about the disease. The organization evaluated their research grants program by looking at grants awarded from 2003-2011. During that time, 66 grants were awarded totaling $9.15...
BOULDER, Colo., May 15, 2013 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today announced presentations on its MEK inhibitors, MEK162 (licensed to Novartis) and selumetinib (licensed to AstraZeneca) at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 31 - June 4, 2013 in Chicago, Illinois. Both MEK inhibitors are expected to advance into Phase 3 trials in 2013: Novartis expects to evaluate MEK162 in NRAS- and BRAF-mutant melanoma...
HOUSTON, May 15, 2013 /PRNewswire/ -- ApoCell, Inc. announced that the first prototypes of its ApoStream(TM) circulating tumor cell (CTC) isolation system have been delivered to select investigator sites including SAIC-Frederick Inc. (SAIC-F) in support of the National Cancer Institute (NCI). The delivery is part of a $2.9 million subcontract awarded to ApoCell in Q1-2011 by SAIC-F to develop a device capable of isolating live cancer cells from small volumes of blood. While...
The primary goal of the Lung Cancer Asbestos Victims Center is helping all US Navy Veterans, who have been diagnosed with mesothelioma, or any type of lung cancer, and they are asking one simple question, "Where were you exposed to asbestos on your ship, because where you were exposed can make a huge difference when it comes to financial compensation, especially for US Navy Veterans, who are victims of mesothelioma?" If a US Navy Veteran has been diagnosed with mesothelioma, the...
Jean LaMantia, Registered Dietitian, Cancer Survivor and Author of The Essential Cancer Treatment Nutrition Guide and Cookbook is pleased to introduce an Opportunity to Make a Difference in the Life a Cancer Patient Today. Toronto, ON (PRWEB) May 14, 2013 Cancer patients and nutrition professionals have been enthusiastic in their praise of The Essential Cancer Treatment Nutrition Guide and Cookbook, which is bringing comfort to many. Designed with the nutritional needs of the cancer...
Kids II Connecting and Empowering Moms across the Nation Atlanta, GA (PRWEB) May 14, 2013 The Pink Power Mom Program, now in its seventh year, proudly announces the call for this year’s nominations starting on Mother’s Day, May 12. Every year, Kids II® recognizes and rewards eight women for their fight against breast cancer and honors these incredible women as Pink Power Moms. The Pink Power Moms are selected due to the inspiration they give their families, friends and others...
KANSAS CITY, Kan., May 14, 2013 /PRNewswire/ -- Actress Angelina Jolie has sparked a national conversation after opting to undergo a preventative double mastectomy after testing positive for the breast cancer gene. Jolie's family history combined with her test results put her at high risk for breast and ovarian cancer according to news reports. "Personal and family history are the major determinants for genetic testing," said Jennifer Klemp, Ph.D, MPH, director, Breast Cancer...
Spring dedication at Huntsville Botanical Garden displays new gardens symbolizing hope and courage in the fight against cancer HUNTSVILLE, Ala., May 14, 2013 /PRNewswire/ -- One brave woman currently undergoing chemotherapy and two cancer survivors, their families, friends and members of the Huntsville community celebrated life today at the Intergraph(® )Garden of Hope spring dedication in a poignant display of inspiration at the Huntsville Botanical Garden. (Logo:...
